Customer Center
Login | Register


Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More

Luminex® Blog

Sharing Multiplex Solutions at xMAP® Connect 2016

Learn about the diverse applications of xMAP Technology and spark inspiration for your next experiment

Most conferences focus on research advances and the development of therapies for specific diseases. xMAP® Connect is different. Whether you’re a multiplexing expert eager to share your work or just getting started – xMAP Connect is the premier event for networking with fellow xMAP enthusiasts and sharing best practices…”

Continue Reading…

We Are Luminex

We Are Luminex


At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.

Watch more videos >

Luminex on Twitter

Last chance to visit us at booth 5! Come grab a coffee while there’s still time. #ECCMID2017
h J R
We realize that your testing needs differ during the day, week, or year. Check out our flexible solutions at booth 5. #ECCMID2017
h J R
Another poster today on BK virus quantitation on the ARIES platform: P1909 at lunch break. #ECCMID2017
h J R

Latest News

April 20
Luminex Corporation To Present At Bank Of America Merrill Lynch 2017 Health Care Conference

April 10
Luminex Corporation First Quarter Earnings Release Scheduled for May 1, 2017

March 1
Luminex Corporation To Present At The Barclays Global Healthcare Conference

February 21
Luminex Corporation Announces Initiation of Cash Dividend

February 6
Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results

January 9
Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance; To Present at 35th Annual J.P. Morgan Healthcare Conference


22-25 April
Vienna, AT

16-18 May
Hannover, DE

Scottish Diagnostic Virology Group Meeting
26 May
Stirling, UK

Drug Discovery Summit
12-13 June
Berlin, DE

Microbiology Meeting
31 August-1 September